Marianne Antonius Jakobsen

Marianne Antonius Jakobsen

Auto-generated profile, based on publicly available information

Marianne Antonius Jakobsen

Department of Clinical Immunology Odense University Hospital Odense Denmark

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2004 in The Lancet
Verified
Journal Article
Closed access
HGH Bobby Gaspar
H Bobby Gaspar
KPKathryn L Parsley
Kathryn L Parsley
SHSteven Howe
Steven Howe
DKDoug King
Doug King
KGKimberly Gilmour
Kimberly Gilmour
ATAdrian J. Thrasher
Adrian J. Thrasher

13 October 2011 in Transfusion
Verified
Journal Article
Closed access
PDF file
FCFrederik Clausen
Frederik Clausen
MCMette Christiansen
Mette Christiansen
RSRudi Steffensen
Rudi Steffensen
SJSteffen Jørgensen
Steffen Jørgensen
CNChristian Nielsen
Christian Nielsen
MDMorten Hanefeld Dziegiel
Morten Hanefeld Dziegiel

24 May 2014 in Prenatal Diagnosis
Verified
Journal Article
Closed access
PDF file
FCFrederik Clausen
Frederik Clausen
RSR. Steffensen
R. Steffensen
MCM. Christiansen
M. Christiansen
MRM. Rudby
M. Rudby
MJM. A. Jakobsen
M. A. Jakobsen
NGN. Grunnet
N. Grunnet

14 September 2014 in Journal of Clinical Immunology
Verified
Journal Article
Closed access
PDF file
CNChristian Nielsen
Christian Nielsen
MJMarianne A. Jakobsen
Marianne A. Jakobsen
MLMartin Larsen
Martin Larsen
AMAmanda C. Müller
Amanda C. Müller
SHSoren Hansen
Soren Hansen
TBTorben Barington
Torben Barington

25 April 2006 in Scandinavian Journal of Immunology
Verified
Journal Article
Closed access
PDF file
MJM. A. Jakobsen
M. A. Jakobsen
RPR. K. Petersen
R. K. Petersen
KKK. Kristiansen
K. Kristiansen
MLM. Lange
M. Lange
SLS. T. Lillevang
S. T. Lillevang

16 March 2017 in Orphanet Journal of Rare Diseases
Verified
Journal Article
Open access
PDF file
AAAnne Aabom
Anne Aabom
KAKlaus E. Andersen
Klaus E. Andersen
CFChristina Ringmann Fagerberg
Christina Ringmann Fagerberg
NFNiels Fisker
Niels Fisker
MJMarianne A. Jakobsen
Marianne A. Jakobsen
ABAnette Bygum
Anette Bygum
With a potentially early onset, hereditary angioedema (HAE) requires special knowledge also in infancy and early childhood. In children from families with HAE, the diagnosis should be confirmed or refuted early, which can be difficult. Studies of childhood HAE and the diagnostic approaches are limited. Our aim was to investigate the entire Danish cohort of children with HAE and non-HAE children of HAE patients for diagnostic approaches and clinical characteristics. We included 41 children: 22 with HAE and 19 non-HAE. Of the HAE children, 14 were symptomatic—median age at onset was 4 [1–11] years. The first attack was peripheral in 8/14 children and abdominal in 6/14 children, i.e. no one had their first attacks in the upper airways. Most children had less than one attack per month. All of the symptomatic children had been treated with tranexamic acid and/or C1 inhibitor concentrate. Unlike in other countries, androgens were not used in our pediatric cohort. Home therapy with C1 inhibitor concentrate was established in 9 cases: 6 children were trained in self-administration and 3 children were treated by parents. Of the children, 10 had been diagnosed by symptoms, including 3 without family history—median age of diagnosis among these children was 5.35 [2–13.2] years. In 31 children, HAE was diagnosed or refuted before symptoms by blood samples. In 23 of these children, complement values were investigated, and in 9 cases genetic testing was added to the complement measurements. In 8 children recently investigated, genetic testing was first choice. Cord blood was used for complement measurements in 9 children and for genetic testing in 4 children. Results of complement measurements were equivocal in several cases, especially in the cord blood samples, and the sensitivity of low complement C4 for the diagnosis of HAE was 75%. We investigated clinical characteristics in all Danish children with HAE. The rate of home therapy was high and androgens had been avoided. Complement values were often equivocal, especially in cord blood samples. Consequently, we have changed diagnostic practice to early genetic testing in children where the family mutation is known.